AR and gastric cancer: In the healthy individuals cohort, the addition of ATRA caused the AR to show the opposite trend, which may be due to the difference between the immune microenvironment in normal subjects and that in GC patients, which precisely indicateed that our prediction model presented specificity in GC patients.